← FDA DRUG APPROVALS

FDA NDA · NDA013264

HYDROMOX

Sponsor: LEDERLE

APPLICATION
NDA013264
TYPE
NDA
ORIGINAL APPROVAL
1963-04-10
LATEST ACTION
1987-07-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROMOXDiscontinued
QUINETHAZONE 50MG · TABLET · ORAL

Approval history

1987-07-15Manufacturing (CMC) · Supplement 26 · standardAP
1983-12-15Manufacturing (CMC) · Supplement 25 · standardAP
1982-05-21Manufacturing (CMC) · Supplement 24 · standardAP
1980-02-21Manufacturing (CMC) · Supplement 23 · standardAP
1978-06-28Manufacturing (CMC) · Supplement 22 · standardAP
1978-06-28Manufacturing (CMC) · Supplement 21 · standardAP
1978-06-07Labeling · Supplement 20 · standardAP
1963-04-10Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →